Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$28.4M
-9.5% from 2023
Prescriptions
19K
$1,513.15 per claim
Patients
2,842
2,785 prescribers
Total spending, 2024
$28.5M
$10,007.66 per patient
Medicare prescription drug plans paid $28.4M for Oxtellar Xr in 2024, for 18,801 prescriptions and refills to 2,842 patients (down 9.5% from 2023). The average cost per claim was $1,513.15.
Texas had the highest Medicare cost for Oxtellar Xr in 2024: $2.1M for 1,444 claims, followed by New York ($2.0M).
Thulasiraman P Ravichandran, neurology in Milwaukee, WI, had the highest Medicare cost for Oxtellar Xr in 2024: 63 claims costing $182K.
Oxtellar Xr is made by Supernus Pharmaceuticals, Inc. (SUPN), listed in the Medicare spending data as Supernus Pharma.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Thulasiraman P Ravichandran Milwaukee, WI | Neurology | 63 | 15 | $182K |
| Kelley Phillips Kalamazoo, MI | Physician Assistant | 54 | Under 11 | $138K |
| Evan K Sandok |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 2,830 | 21,481 | 2,913 | $29.0M |
| 2023 | 2,845 | 21,036 | 2,885 | $31.4M |
| 2024 | 2,785 | 18,801 | 2,842 | $28.4M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Neurology |
| 44 |
| Under 11 |
| $121K |
| Ty Brown Crestview Hills, KY | Neurology | 35 | Under 11 | $114K |
| Dragos Sabau Indianapolis, IN | Neurology | 43 | Under 11 | $106K |
| Alice Lam Boston, MA | Neurology | 28 | Under 11 | $100K |
| Kevin R Kristl Granger, IN | Neurology | 56 | Under 11 | $100K |
| Sarita V Maturu Columbus, OH | Neurology | 62 | Under 11 | $97K |
| Mark Callow West Chester, OH | Neurology | 28 | Under 11 | $92K |
| Boris Rubashkin Houston, TX | Psychiatry | 64 | Under 11 | $87K |
| Christopher C Laganke Cullman, AL | Neurology | 83 | Under 11 | $85K |
| Jianfeng Zeng Lumberton, NC | Neurology | 40 | Under 11 | $83K |
| Nabil A Khandker Columbus, OH | Neurology | 52 | Under 11 | $77K |
| Maysaa M Basha Detroit, MI | Neurology | 42 | Under 11 | $76K |
| Jennifer L Irwin Indianapolis, IN | Physician Assistant | 34 | Under 11 | $75K |
| Rodney A Radtke Durham, NC | Neurology | 29 | Under 11 | $74K |
| Aline Herlopian New Haven, CT | Neurology | 66 | Under 11 | $74K |
| James P Valeriano Pittsburgh, PA | Neurology | 54 | Under 11 | $73K |
| Ravi A Patel Apple Valley, CA | Neurology | 60 | 11 | $71K |
| Masanori Takeoka Boston, MA | Neurology | 21 | Under 11 | $68K |
| Dipakkumar P Pandya Annandale, NJ | Neurology | 15 | Under 11 | $67K |
| George L Morris III Milwaukee, WI | Epileptologists | 22 | Under 11 | $67K |
| Manoj Raghavan Milwaukee, WI | Neurology | 26 | Under 11 | $67K |
| Michael B Russo Honolulu, HI | Neurology | 50 | Under 11 | $67K |
| Paul Motika Portland, OR | Neurology | 24 | Under 11 | $66K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Supernus Pharma SUPN | 18,806 | $28.5M |